NF-κB Signaling and Carcinogenesis
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
447-462
Author(s):
Takashi Okamoto, Takaomi Sanda and Kaori Asamitsu
Busulphan in Blood and Marrow Transplantation: Dose, Route, Frequency and Role of Therapeutic Drug Monitoring
Journal:
Current Clinical Pharmacology
Volume:
2
Page:
75-91
Author(s):
Christa Ellen Nath and Peter John Shaw
Can we Target the Chemokine Network for Cancer Therapeutics?
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
659-670
Author(s):
Ryan Giles and Robert D. Loberg
Targeting the EGFR Pathway for Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
3483-3492
Author(s):
James B. Johnston, Sri Navaratnam, Marshall W. Pitz, Jerry M. Maniate, Emilia Wiechec, Heinrich Baust, Joel Gingerich, Georgios P. Skliris, Leigh C. Murphy and Marek Los
NF-κ B and Rheumatic Diseases
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
359-372
Author(s):
Takashi Okamoto
MRI of Central Nervous System (CNS) Vasculitis
Journal:
Current Medical Imaging
Volume:
2
Page:
425-434
Author(s):
Kazuo Abe
Immunotoxins in the Treatment of Hematologic Malignancies
Journal:
Current Drug Targets
Volume:
7
Page:
1301-1311
Author(s):
Robert J. Kreitman and Ira Pastan
A Clinical Scoring System as Useful as FNAC in the Diagnosis of Tuberculous Lymphadenitis in HIV Positive Patients
Journal:
Current HIV Research
Volume:
4
Page:
459-462
Author(s):
Murli L. Mathur, Vimlesh Purohit, Satya D. Purohit, Satya D. Purohit and Murli L. Mathur
What is the Best Option to Cure Patients with Resistant/Relapsing Hodgkins Disease?
Journal:
Current Stem Cell Research & Therapy
Volume:
1
Page:
419-424
Author(s):
Massimo Magagnoli, Monica Balzarotti, Luca Castagna, Monica Demarco and Armando Santoro
Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2849-2861
Author(s):
Konstantinos N. Syrigos and Anastasios J. Karayiannakis